TEGRETOL Safety Questions, TEGRETOL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TEGRETOL. Our extensive database of TEGRETOL adverse events and TEGRETOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TEGRETOL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TEGRETOL Safety Reports

Total TEGRETOL reports: 685.
TEGRETOL FDA safety alerts: 2005 2007 .
Reported deaths: 40    Reported hospitalizations: 304.
Take TEGRETOL Side Effects Survey or Share Your TEGRETOL Story. TEGRETOL Usage.

Showing 1-75 of 685 Next >

Pharmacist from JAPAN reported TEGRETOL problem on Feb 15, 2007. Male patient, 59 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with ALDACTONE, VASOLAN, SELBEX, JUVELA, ALINAMIN F, ALLOPURINOL, WARFARIN, TOWAMIN. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 26, 2007. Female patient, 35 years of age, weighting 195.0 lb, was diagnosed with affective disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alopecia, dehydration, hepatic failure, multi-organ failure, respiratory failure, stevens-johnson syndrome. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TEGRETOL problem on Feb 22, 2007. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with facial spasm, cerebral infarction, nasopharyngitis, asthma and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow, blood lactate dehydrogenase increased, chills, diarrhoea, eczema, enterocolitis, idiopathic thrombocytopenic purpura, lymphocyte count decreased. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with PLETAL, COMMON COLD MEDICINE, SPIROPENT, RIVOTRIL. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Physician from FRANCE on Feb 23, 2007. Male patient, weighting 165.3 lb, was diagnosed with hyperaesthesia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: angioedema, urticaria. TEGRETOL dosage: unknown. During the same period patient was treated with LAROXYL. Patient recovered.

Health Professional from SWITZERLAND reported TEGRETOL problem on Feb 16, 2007. Female patient, 83 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, atrioventricular block first degree, blood potassium decreased, blood sodium decreased, dehydration, dizziness, hypokalaemia, hyponatraemia, nausea. TEGRETOL dosage: 1200 MG/DAY. During the same period patient was treated with INDAPAMIDE, LASIX, CALPEROS, MYSOLINE, ASPIRIN, DUPHALAC. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from UNITED KINGDOM on Feb 15, 2007. Male patient, child 6 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, convulsion, malabsorption, steatorrhoea. TEGRETOL dosage: 170MG MANE / 200MG NOCTE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Feb 20, 2007. Female patient, 64 years of age, weighting 319.9 lb, was diagnosed with convulsion, osteoporosis and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abasia, activities of daily living impaired, bone neoplasm, fall, muscular weakness, sarcoma, weight decreased. TEGRETOL dosage: unknown. During the same period patient was treated with ACTONEL, FORTEO. Patient was hospitalized. Patient died on 01/20/2006.

TEGRETOL problem was reported by a Consumer or non-health professional from GERMANY on Feb 20, 2007. Female patient, 40 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: benign renal neoplasm, cholelithiasis, convulsion, haemangioma, liver function test abnormal, thyroid neoplasm. TEGRETOL dosage: 1200 MG/D. During the same period patient was treated with CLINOVIR. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported TEGRETOL problem on Feb 20, 2007. Male patient, 60 years of age, was diagnosed with neuralgia, nausea and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, dysarthria, feeling drunk, gait disturbance, vertigo. TEGRETOL dosage: 400MG DAILY. During the same period patient was treated with EPILIM, ENDEP, NUELIN, MAXOLON, PREDNISOLONE, FUROSEMIDE, SPIRONOLACTONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from JAPAN on Feb 20, 2007. Female patient, child 6 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: pyrexia. TEGRETOL dosage: 240 MG/DAY. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported TEGRETOL problem on Feb 20, 2007. Female patient, 31 years of age, was diagnosed with contraception and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abortion induced. TEGRETOL dosage: 400 MG, QD. During the same period patient was treated with IMPLANON, LEVOTHYROXINE. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from AUSTRALIA on Feb 20, 2007. Female patient, 41 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, mucosal inflammation, rash, skin lesion. TEGRETOL dosage: 400 MG DAILY. During the same period patient was treated with COLOXYL WITH SENNA, THIAMINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 21, 2007. Male patient, 48 years of age, weighting 138.9 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: anorexia, brain damage, coma, convulsion, dizziness, epilepsy, headache, hypermetropia, insomnia. TEGRETOL dosage: unknown. During the same period patient was treated with GARDAN, MYSOLINE, TYLENOL. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on Feb 21, 2007. Female patient, 61 years of age, weighting 90.39 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, convulsion, fall, headache, loss of consciousness, road traffic accident, spinal fracture, tremor. TEGRETOL dosage: 200 MG, TID. During the same period patient was treated with RIVOTRIL, SARIDON, DIPYRONE. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 22, 2007. Female patient, child 8 years of age, weighting 48.50 lb, was diagnosed with cerebral disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: epistaxis, haematoma, hypersensitivity, petechiae, rash macular. TEGRETOL dosage: 2 TABLETS OF 200 MG/DAY. Patient recovered.

TEGRETOL problem was reported by a Health Professional from BRAZIL on Feb 21, 2007. Male patient, 18 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: calcifying fibrous pseudotumour, gingival bleeding, gingival discolouration, gingival hyperplasia, histology abnormal, pyogenic granuloma, tooth deposit. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with GARDAN, HYDANTAL. Patient recovered.

Physician from JAPAN reported TEGRETOL problem on Feb 23, 2007. Female patient, 74 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: convulsion. TEGRETOL dosage: unknown. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from JAPAN on Feb 22, 2007. Male patient, child 4 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: convulsion. TEGRETOL dosage: unknown. Patient recovered.

Physician from JAPAN reported TEGRETOL problem on Feb 19, 2007. Female patient was diagnosed with hypoaesthesia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, dizziness postural, fall, hyporeflexia, incoherent, muscular weakness, transient ischaemic attack. TEGRETOL dosage: 1200 MG/DAY. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from JAPAN on Feb 19, 2007. Male patient, 17 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with ALEVIATIN, EXCEGRAN, MYSTAN, DEPAKENE, PRIMIDONE. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 20, 2007. Female patient was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abasia, arthralgia, feeling cold, feeling hot, hypoaesthesia, micturition urgency, myalgia, nausea, paralysis. TEGRETOL dosage: 200 MG, QD. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Feb 21, 2007. Female patient, 24 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 20, 2007. Female patient was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abasia, arthralgia, feeling cold, feeling hot, hypoaesthesia, micturition urgency, myalgia, nausea, paralysis. TEGRETOL dosage: 200 MG, QD. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from AUSTRALIA on Feb 20, 2007. Male patient, child 8 years of age, weighting 66.14 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: epistaxis, haematemesis, haemoglobin decreased, platelet count decreased, thrombocytopenia. TEGRETOL dosage: 12 ML DAILY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Feb 21, 2007. Male patient, 32 years of age, was diagnosed with headache and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cranial nerve disorder. TEGRETOL dosage: 200 MG/DAY. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on Feb 23, 2007. Female patient, 24 years of age, was diagnosed with neurocysticercosis and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anaemia, hepatitis, urinary tract infection, weight decreased. TEGRETOL dosage: 1000 TO 1200 MG/DAY. Patient recovered.

Physician from JAPAN reported TEGRETOL problem on Feb 23, 2007. Female patient, 22 years of age, weighting 127.9 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abscess, collagen disorder, feeling cold, pain, raynaud's phenomenon. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with EXCEGRAN, MYSTAN AZWELL. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2007. Female patient, 33 years of age, weighting 198.4 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: shock. TEGRETOL dosage: unknown. Patient died.

Physician from JAPAN reported TEGRETOL problem on Feb 23, 2007. Female patient was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: dysphonia, glossitis, oral mucosa erosion, stomatitis. TEGRETOL dosage: unknown. During the same period patient was treated with MUCOSTA, NEUROTROPIN. Patient recovered.

TEGRETOL problem was reported by a Physician from UNITED KINGDOM on Feb 22, 2007. Female patient, 25 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: brain neoplasm malignant, surgery. TEGRETOL dosage: 200 MG, BID. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 23, 2007. Male patient, 48 years of age, weighting 138.9 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: anorexia, brain damage, coma, convulsion, dizziness, dry skin, epilepsy, headache, hypermetropia. TEGRETOL dosage: 200 MG, TID. During the same period patient was treated with GARDAN, MYSOLINE, TYLENOL, TRILEPTAL. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 23, 2007. Male patient, child 10 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood mercury abnormal, condition aggravated, epilepsy. TEGRETOL dosage: 7.5 ML, BID. During the same period patient was treated with EPILIM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 26, 2007. Female patient, 61 years of age, weighting 90.39 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, convulsion, fall, headache, loss of consciousness, road traffic accident, spinal fracture, tremor. TEGRETOL dosage: 200 MG, TID. During the same period patient was treated with RIVOTRIL, SARIDON, DIPYRONE, HIDANTAL. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from JAPAN on Feb 23, 2007. Female patient, child 8 years of age, weighting 59.52 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, erythema, lip swelling, neck pain, pyrexia, white blood cell count decreased, white blood cell count increased. TEGRETOL dosage: 300 MG/DAY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TEGRETOL problem on Feb 26, 2007. Female patient was diagnosed with cerebral cyst and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abortion induced, cardiac malposition, congenital tricuspid valve atresia, dextrocardia, heart disease congenital, ultrasound scan abnormal, univentricular heart. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with FOLIC ACID. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from JAPAN on Feb 27, 2007. Male patient, 59 years of age, was diagnosed with cyst and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with SPIRONOLACTONE, VASOLAN, SELBEX, DIGOSIN, WARFARIN, TOWAMIN, TOCOPHERYL NICOTINATE, DICETAMIN. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Feb 26, 2007. Male patient, 63 years of age, weighting 154.3 lb, was diagnosed with facial pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: infection, laboratory test abnormal, rash macular, swelling. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with ANTIHYPERTENSIVES. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from AUSTRALIA on Feb 28, 2007. Male patient, 68 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, coordination abnormal, dysphagia, hyponatraemia, photophobia. TEGRETOL dosage: 800MG DAILY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Feb 28, 2007. Male patient, 35 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: arachnoid cyst, convulsion, hydrocephalus, ileus, megacolon, pneumonia aspiration. TEGRETOL dosage: 1000 MG/DAY. During the same period patient was treated with TIMIPERONE, SULTOPRIDE HYDROCHLORIDE, LEVOMEPROMAZINE MALEATE, LITHIUM CARBONATE, HALOPERIDOL. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from GERMANY on Feb 28, 2007. Female patient, 31 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash pustular, weight increased. TEGRETOL dosage: 400 MG/DAY. Patient recovered.

Pharmacist from JAPAN reported TEGRETOL problem on Mar 06, 2007. Female patient, 85 years of age, was diagnosed with cancer pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: bradycardia, convulsion, overdose, uterine cancer, vomiting. TEGRETOL dosage: 400 MG/DAY. Patient was hospitalized. Patient died on 01/09/2007.

TEGRETOL problem was reported by a Consumer or non-health professional from AUSTRALIA on Feb 28, 2007. Female patient, 25 years of age, was diagnosed with epilepsy, contraception and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abortion induced. TEGRETOL dosage: 600 MG, QD. During the same period patient was treated with IMPLANON. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Mar 01, 2007. Female patient, 17 years of age, weighting 116.8 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, optic nerve injury, optic neuritis, papilloedema, vision blurred. TEGRETOL dosage: 200 MG, QHS. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from SWITZERLAND on Mar 01, 2007. Female patient, 31 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: caesarean section, normal newborn. TEGRETOL dosage: 400 MG/DAY. During the same period patient was treated with CEFUROXIME AXETIL, CIPROFLOXACIN HYDROCHLORIDE. Patient recovered.

Pharmacist from JAPAN reported TEGRETOL problem on Feb 23, 2007. Female patient, child 8 years of age, weighting 59.52 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, erythema, lip swelling, neck pain, pyrexia, white blood cell count decreased, white blood cell count increased. TEGRETOL dosage: 300 MG/DAY. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Physician from JAPAN on Mar 02, 2007. Female patient, 22 years of age, weighting 127.9 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abscess, collagen disorder, feeling cold, pain, raynaud's phenomenon. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with EXCEGRAN, MYSTAN AZWELL. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Mar 12, 2007. Female patient, 33 years of age, weighting 198.9 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: myocarditis, oedema, pulmonary congestion, shock, spleen congestion. TEGRETOL dosage: unknown. During the same period patient was treated with LEVOMEPROMAZINE, PROMETHAZINE, HALOPERIDOL, FLUVOXACIN, LITHIUM CARBONATE, TRIHEXYPHENIDYL, PROMAZEPAM, NITRAZEPAM. Patient died.

TEGRETOL problem was reported by a Physician from JAPAN on Mar 02, 2007. Female patient, 16 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative. TEGRETOL dosage: 400 MG/DAY. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Mar 01, 2007. Female patient, child 7 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: pneumonia mycoplasmal, stevens-johnson syndrome. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Physician from JAPAN on Mar 01, 2007. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatitis fulminant, lymphocyte count decreased, lymphocyte morphology abnormal. TEGRETOL dosage: 100 MG/DAY. Patient recovered.

Pharmacist from UNITED KINGDOM reported TEGRETOL problem on Mar 01, 2007. Female patient was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: dysphagia. TEGRETOL dosage: 400 MG, BID. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on Mar 05, 2007. Female patient, child 8 years of age, weighting 48.50 lb, was diagnosed with cerebral disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, epistaxis, haematoma, hypersensitivity, nausea, petechiae, rash macular. TEGRETOL dosage: 2 TABLETS OF 200 MG/DAY. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Mar 05, 2007. Male patient, 32 years of age, was diagnosed with headache and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: brain damage, headache. TEGRETOL dosage: 200 MG/DAY. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Mar 05, 2007. Female patient, 24 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. TEGRETOL dosage: unknown. During the same period patient was treated with CLONAZEPAM, ACETAZOLAMIDE, ZONISAMIDE, RISPERIDONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported TEGRETOL problem on Mar 05, 2007. Female patient was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: convulsion, fall, fatigue, hallucination, myocardial infarction. TEGRETOL dosage: 400-0-400 MG/DAY. During the same period patient was treated with PRIMIDONE, KEPPRA. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Pharmacist from JAPAN on Mar 05, 2007. Male patient, 69 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block. TEGRETOL dosage: 400 MG AND 200 MG IN TURN. Patient recovered.

Consumer or non-health professional from FRANCE reported TEGRETOL problem on Mar 12, 2007. Male patient, 76 years of age, weighting 127.9 lb, was diagnosed with pain, hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, asthenia, chronic lymphocytic leukaemia, crepitations, granulocytes maturation arrest, lymphocytosis, lymphoid tissue hyperplasia, pyrexia. TEGRETOL dosage: 200 MG, TID. During the same period patient was treated with COAPROVEL. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Physician from FRANCE on Mar 06, 2007. Female patient, 40 years of age, weighting 127.9 lb, was diagnosed with myoclonic epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: bone density decreased, fracture, osteoporosis, vitamin d decreased. TEGRETOL dosage: 900 MG DAILY. During the same period patient was treated with DEPAKENE, RIVOTRIL. Patient recovered.

Physician from FRANCE reported TEGRETOL problem on Mar 06, 2007. Male patient, 32 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: azoospermia, infertility. TEGRETOL dosage: 800 MG/DAY. Patient recovered.

TEGRETOL problem was reported by a Physician from JAPAN on Mar 13, 2007. Male patient, 34 years of age, weighting 154.3 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, c-reactive protein increased, chest x-ray abnormal, hypogammaglobulinaemia, interstitial lung disease, lymphocyte stimulation test positive. TEGRETOL dosage: 800 MG/DAY. During the same period patient was treated with RIVOTRIL, EXCEGRAN, ZONISAMIDE, DEPAKENE, PHENYTOIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported TEGRETOL problem on Mar 06, 2007. Female patient, 54 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: allergic bronchitis, amblyopia, blood cholesterol abnormal, blood cholesterol increased, cataract, convulsion, coordination abnormal, eosinophilia. TEGRETOL dosage: 400MG. During the same period patient was treated with SINGULAIR, BECOTIDE, FLIXONASE, LOSEC, TETRACYCLINE. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2007. Female patient, 33 years of age, weighting 198.9 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: myocarditis, oedema, pulmonary congestion, shock, spleen congestion. TEGRETOL dosage: unknown. During the same period patient was treated with LEVOMEPROMAZINE, PROMETHAZINE, HALOPERIDOL, FLUVOXACIN, LITHIUM CARBONATE, TRIHEXYPHENIDYL, PROMAZEPAM, NITRAZEPAM. Patient died.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Mar 13, 2007. Male patient, weighting 154.3 lb, was diagnosed with cerebral disorder, fear and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: benign tumour excision, brain neoplasm, cerebrovascular accident. TEGRETOL dosage: 2 TABLETS OF 400 MG/DAY. During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on Mar 07, 2007. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abasia, hypokinesia. TEGRETOL dosage: unknown. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Mar 08, 2007. Male patient, 63 years of age, weighting 154.3 lb, was diagnosed with facial pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: asthenia, infection, laboratory test abnormal, nervousness, rash macular, swelling. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with ANTIHYPERTENSIVES. Patient was hospitalized. Patient recovered.

TEGRETOL problem was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, 71 years of age, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: dysphonia, glossitis, nasopharyngitis, oral mucosa erosion, stomatitis. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with DEPAS, NEUROTROPIN. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Mar 08, 2007. Female patient, 61 years of age, weighting 90.39 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, convulsion, fall, headache, loss of consciousness, road traffic accident, spinal fracture, tremor. TEGRETOL dosage: 200 MG, TID. During the same period patient was treated with CLONAZEPAM, SARIDON, DIPYRONE, HIDANTAL. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 09, 2007. Female patient, 64 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cold sweat, convulsion, nausea, skin reaction, vomiting. TEGRETOL dosage: 200 MG, BID. Patient recovered.

Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Mar 07, 2007. Female patient, 73 years of age, weighting 132.3 lb, was diagnosed with petit mal epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abasia, hypoaesthesia, hypokinesia. TEGRETOL dosage: 400 MG, TID. During the same period patient was treated with ALENDRONATE, ROCALTROL, FOSAMAX. Patient recovered.

TEGRETOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 12, 2007. Female patient, 32 years of age, was diagnosed with mood altered and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, menorrhagia, premenstrual syndrome. TEGRETOL dosage: 600MG NOCTE. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Mar 19, 2007. Female patient, 33 years of age, weighting 198.9 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, myocarditis, oedema, pulmonary congestion, shock, spleen congestion. TEGRETOL dosage: unknown. During the same period patient was treated with LEVOMEPROMAZINE, PROMETHAZINE, HALOPERIDOL, FLUVOXACIN, LITHIUM CARBONATE, TRIHEXYPHENIDYL, PROMAZEPAM, NITRAZEPAM. Patient died.

TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2007. Female patient, 77 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer perforation, liver disorder, photosensitivity reaction, porphyria non-acute, renal failure chronic, thrombocytopenic purpura. TEGRETOL dosage: unknown. During the same period patient was treated with PHENYTOIN, VALPROATE, AMEZINIUM METILSULPHATE, DIGOXIN, RANITIDINE HYDROCHLORIDE, ALFACALCIDOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported TEGRETOL problem on Mar 19, 2007. Female patient, 33 years of age, weighting 198.9 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: biopsy heart abnormal, cardio-respiratory arrest, hepatic congestion, loss of consciousness, lymphocytic infiltration, myocardial fibrosis, myocarditis. TEGRETOL dosage: unknown. During the same period patient was treated with NITRAZEPAM, TRIHEXYPHENIDYL, PROMETHAZINE, LEVOMEPROMAZINE, HALOPERIDOL, FLUVOXAMINE MALEATE, ETIZOLAM, LITHIUM CARBONATE. Patient died.

TEGRETOL problem was reported by a Physician from JAPAN on Mar 13, 2007. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, eosinophil count increased, gamma-glutamyltransferase increased, human herpes virus 6 serology positive. TEGRETOL dosage: 200 MG, BID. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED KINGDOM reported TEGRETOL problem on Mar 12, 2007. Male patient, 65 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: myalgia, myopathy. TEGRETOL dosage: unknown. During the same period patient was treated with DIPYRIDAMOLE, INSULIN, SIMVASTATIN, CELECOXIB, RAMIPRIL, FRUSEMIDE. Patient recovered.

Showing 1-75 of 685 Next >

Ask Our Patient Community about TEGRETOL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant